Dong An

1.1k total citations
38 papers, 868 citations indexed

About

Dong An is a scholar working on Organic Chemistry, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Dong An has authored 38 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 8 papers in Infectious Diseases and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Dong An's work include Asymmetric Synthesis and Catalysis (9 papers), Viral Infections and Immunology Research (7 papers) and Animal Disease Management and Epidemiology (6 papers). Dong An is often cited by papers focused on Asymmetric Synthesis and Catalysis (9 papers), Viral Infections and Immunology Research (7 papers) and Animal Disease Management and Epidemiology (6 papers). Dong An collaborates with scholars based in China, United States and Australia. Dong An's co-authors include Suoqin Zhang, Yan‐Sen Fan, Guofeng Liu, Liangyu Zheng, Guangliang Zhang, Jigang Gao, Wei Kong, Chunlai Jiang, Yijun Jiang and Shiyang Sun and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Chemical Communications.

In The Last Decade

Dong An

35 papers receiving 852 citations

Peers

Dong An
Liliana M. Finkielsztein Argentina
Allan M. Prior United States
S Mori Japan
Xinyong Liu China
Lucas Fabián Argentina
Anna Helmin–Basa Poland
Ming Bu China
Norio Murai Japan
Haiying Li China
Robin J. Thomson Australia
Liliana M. Finkielsztein Argentina
Dong An
Citations per year, relative to Dong An Dong An (= 1×) peers Liliana M. Finkielsztein

Countries citing papers authored by Dong An

Since Specialization
Citations

This map shows the geographic impact of Dong An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong An more than expected).

Fields of papers citing papers by Dong An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong An. The network helps show where Dong An may publish in the future.

Co-authorship network of co-authors of Dong An

This figure shows the co-authorship network connecting the top 25 collaborators of Dong An. A scholar is included among the top collaborators of Dong An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong An. Dong An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Xuejie, Qikai Zhang, Yifei Zhang, et al.. (2025). Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis. Journal of Biomedical Science. 32(1). 9–9. 2 indexed citations
2.
Xiao, Peng, Geng Li, Elizabeth W. Howerth, et al.. (2025). A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates. Journal of Virology. 99(4). e0199024–e0199024. 1 indexed citations
3.
Yang, Zhe, Dong An, Qianyu Zhang, et al.. (2025). Tunable Neuromorphic Computing for Dynamic Multi-Timescale Sensing in Motion Recognition. Cyborg and Bionic Systems. 6. 412–412.
4.
Zhou, Xuejiao, Zhengwei Yuan, Cheng Chen, et al.. (2025). Biomarker research for Henoch-Schönlein purpura nephritis based on “omics” techniques. Frontiers in Medicine. 12. 1626324–1626324.
5.
Gao, Xuejie, Liangning Hu, Ke Hu, et al.. (2024). EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma. Acta Biochimica et Biophysica Sinica. 56(7). 1055–1064. 1 indexed citations
6.
An, Dong, Xiaoli Huang, Shuqing Jiang, & Tian Cui. (2023). Pressure-Induced Extraction of Hydrazine Crystals by the Eutectoid Reaction in Hydrazine Monohydrate. The Journal of Physical Chemistry C. 127(43). 21299–21304. 1 indexed citations
7.
8.
Zhou, Peiwen, Zonghui Li, Dong An, et al.. (2020). Research progress and challenges to coronavirus vaccine development. Journal of Medical Virology. 93(2). 741–754. 14 indexed citations
9.
10.
An, Dong, Hao Feng, Hu Chen, et al.. (2018). JNK1 Mediates Lipopolysaccharide-Induced CD14 and SR-AI Expression and Macrophage Foam Cell Formation. Frontiers in Physiology. 8. 1075–1075. 17 indexed citations
11.
Gao, Jigang, Yingying Chen, Guofeng Liu, et al.. (2018). Asymmetric Synthesis of Indoline–Benzodiazepine Scaffold Catalyzed by Chiral Imidodiphosphoric Acids. Asian Journal of Organic Chemistry. 7(4). 697–701. 12 indexed citations
12.
An, Dong, Hao Feng, Fuqiang Zhang, et al.. (2017). CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation. Journal of Biological Chemistry. 292(35). 14391–14400. 26 indexed citations
13.
Liu, Guofeng, Dong An, Guangliang Zhang, et al.. (2017). Highly Enantioselective Friedel–Crafts Reactions of Indoles with Isatins Catalyzed by Chiral Imidodiphosphoric Acids. Asian Journal of Organic Chemistry. 6(7). 807–811. 15 indexed citations
14.
15.
Zhang, Fuqiang, Hao Feng, Dong An, et al.. (2015). The Matricellular Protein Cyr61 Is a Key Mediator of Platelet-derived Growth Factor-induced Cell Migration. Journal of Biological Chemistry. 290(13). 8232–8242. 22 indexed citations
16.
An, Dong, Wei Liu, Qunying Mao, et al.. (2014). Analysis of Cross-Reactive Neutralizing Antibodies in Human HFMD Serum with an EV71 Pseudovirus-Based Assay. PLoS ONE. 9(6). e100545–e100545. 25 indexed citations
17.
Sun, Shiyang, Liping Jiang, Zhenglun Liang, et al.. (2014). Evaluation of monovalent and bivalent vaccines against lethalEnterovirus71 andCoxsackievirusA16 infection in newborn mice. Human Vaccines & Immunotherapeutics. 10(10). 2885–2895. 39 indexed citations
18.
Li, Xiaojun, Weiheng Su, Dong An, et al.. (2013). Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virology Journal. 10(1). 250–250. 31 indexed citations
19.
Lin, Xü, et al.. (2012). Replication kinetics of coxsackievirus A16 in human rhabdomyosarcoma cells. Virologica Sinica. 27(4). 221–227. 4 indexed citations
20.
Ma, Hongxia, Lin Xu, Dong An, et al.. (2012). Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum. Journal of Virological Methods. 187(2). 362–367. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liliana M. Finkielsztein Breakdown of academic impact, for papers by Allan M. Prior Breakdown of academic impact, for papers by S Mori Breakdown of academic impact, for papers by Xinyong Liu Breakdown of academic impact, for papers by Lucas Fabián Breakdown of academic impact, for papers by Anna Helmin–Basa Breakdown of academic impact, for papers by Ming Bu Breakdown of academic impact, for papers by Norio Murai Breakdown of academic impact, for papers by Haiying Li Breakdown of academic impact, for papers by Robin J. Thomson
Rankless by CCL
2026